Core Viewpoint - The company has reported a revenue of RMB 645.02 million for the year, representing a year-on-year growth of 18.65%, with a net profit attributable to shareholders of RMB 123.83 million, indicating strong performance in the biopharmaceutical sector [5][26]. Company Overview - The company specializes in providing recombinant proteins, antibodies, and other key biological reagents and technical services, aiming to support global biopharmaceutical companies and research institutions in drug development and production [4][5]. - The company serves major clients including top global pharmaceutical firms such as Johnson & Johnson, Pfizer, and Novartis, as well as notable domestic companies like Innovent Biologics and WuXi AppTec [5][24]. Financial Performance - The company achieved a revenue of RMB 645.02 million, with a net profit of RMB 123.83 million, reflecting a solid growth trajectory in its core business [5][26]. - The profit distribution plan approved by the board includes a cash dividend of RMB 4.00 per 10 shares and a capital reserve transfer of 5 shares for every 10 shares held [3]. Product and Service Offerings - The main products include recombinant proteins, antibodies, and various assay kits, which are essential for drug development and clinical research [5][8]. - The company has developed nearly 50 high-quality GMP-grade products, ensuring compliance with stringent quality management standards [6][18]. Market Applications - The company's products are widely used in antibody drug development, cell and gene therapy, antibody-drug conjugates (ADCs), and neuroscience research, addressing critical needs in these rapidly evolving fields [17][19][20]. - The company provides comprehensive solutions for CAR-T cell therapy development, including specific antibodies and reagents for quality assessment [17]. Business Model - The company employs a procurement model that emphasizes supplier management and quality control, ensuring a steady supply of essential raw materials for production [21]. - The production process follows a structured approach, with rigorous quality control measures in place to maintain high standards [22][23]. - The sales strategy leverages both online and offline marketing channels, establishing partnerships with leading companies in the biotechnology and life sciences sectors to enhance market reach [24].
北京百普赛斯生物科技股份有限公司